相关实验视频

Updated: Jun 19, 2025

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

基于CRISPR的基因编辑在血液学中的CRISPR-Cas系统和临床应用,重点是遗传的生殖线倾向于血液学恶性瘤

Rina Kansal^1,2

¹Molecular Oncology and Genetics, Diagnostic Laboratories, Versiti Blood Center of Wisconsin, Milwaukee, WI 53233, USA.

|July 27, 2024

概括

基于CRISPR的基因编辑正在彻底改变遗传疾病的治疗. 最近对状细胞贫血和β-thalassemia的批准为其他遗传性血液疾病和癌症倾向提供了希望.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
生物技术是生物技术.

背景情况:

克里斯普尔-Cas9基因编辑已经成为遗传疾病的变革性治疗方式.
克里斯普尔-卡斯9-单导引RNA (sgRNA) 系统的发现有着悠久的历史,可以追溯到1987年.
最近的临床成功,比如对状细胞贫血和输血依赖β-血病的批准,突显了CRISPR的潜力.

研究的目的:

为了提供CRISPR-Cas9-sgRNA基因编辑历史的时间概述.
总结目前的临床研究环境,用于用CRISPR治疗的血液病.
为了展示遗传性血液病和骨髓衰竭综合征的基因疗法的进展.

主要方法:

关于CRISPR-Cas9-sgRNA发现和发展的历史审查.
分析当前的临床研究和在血液病中的应用.
对基因疗法在遗传性血液疾病和骨髓衰竭综合征方面的进展进行审查.

主要成果:

自CRISPR-Cas9-sgRNA技术发现以来,它已经取得了重大进展.
临床应用正在扩大,最近批准用于严重的状细胞贫血和依赖输血的β-thalassemia.
基因疗法在遗传性血液病和骨髓衰竭综合征方面表现有前途.

结论:

基于CRISPR的基因编辑为遗传性血液疾病提供了重要的治疗潜力.
持续的研究和开发对于将CRISPR应用扩展到其他遗传疾病至关重要.
这项技术对患有生殖线倾向于血液恶性瘤的患者具有前景.

关键词:

这就是CRISPR-Cas.修复DNA的修复DNA的修复急性骨髓性白血病 (AML) 是一种急性骨髓性白血病.骨髓功能衰竭骨髓功能衰竭基因编辑基因编辑基因治疗的基因疗法血液学癌症血液学癌症遗传的生殖线倾向性导致癌症.骨髓发育不良综合征骨髓状瘤是什么样子的

更多相关视频

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

CRISPR and crRNAs

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...

Homologous Recombination

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...

What is Genetic Engineering?

What is Genetic Engineering?